Home » Online Course on Pharma Project Management Begins Jan. 23
Online Course on Pharma Project Management Begins Jan. 23
PharmaManufacturing.com
01/02/2006
This online instructor-led, interdisciplinary course was created for prospective students in both management and engineering and can be applied to many Stevens’ masters programs and the MBA in Technology Management. It is one of many pharmaceutical-oriented courses offered under the WebPharma banner that are designed to appeal to industry professionals as well as those who want to enter the pharmaceutical industry.
The course deals with the problems of managing a project for the purpose of achieving a specific objective. Both operational and conceptual issues are considered. Operational issues include definition, planning, implementation, control and evaluation of the project. Conceptual issues include project management vs. hierarchical management, matrix organization, project authority, ethics, motivation and morale. Cases, examples and discussions relevant to the pharmaceutical industry illustrate problems in project management and how to resolve them.
Fernando Portes, the course instructor, has 17 years of experience in the pharmaceutical and medical device industries. He has worked at Baxter, Merck, Johnson & Johnson and Wyeth. He managed technology transfer, validation, capital, process improvement, compliance, Six Sigma and procurement projects. (Editor's Note: Portes also authored the article, "Project Management: Know When to Use SOPs, and When Not To," recently posted on this site; click here to read it.)
Portes is a certified project management professional (PMP), a certified quality engineer (CQE) and is listed in Who’s Who in Science and Engineering. He is a member of the Project Management Institute (PMI), of the International Society for Pharmaceutical Engineering (ISPE) and of the Cornell Engineering Alumni Association (CEAA).
For more information, visit www.stevens.edu or contact Stephanie Mannino at (201) 216-5602 or smannino@stevens.edu.
More News:
- 03/10/2010 Concerns Raised about Tromethamine ContaminationFrom Rx-360
- 03/09/2010 Pittcon 2010: Thermo Fisher Scientific Continues in Growth Mode
- 03/09/2010 Conference Report: Maintenance Is Not a Necessary Evil
- 03/05/2010 Glaxo Could Face $6bn Avandia Liability, Says UBSFrom Guardian.co.uk
- 03/05/2010 Planned Job Cuts Drop 41%; 16% for Pharma Industry
- 03/04/2010 AstraZeneca Shuffles, Eliminates Del. R&D Jobs
- 03/03/2010 Germany's Merck to Acquire MilliporeFrom NYTimes.com
- 03/03/2010 FDA Releases Final Guidance on Characterization of Cell Substrates and Bio Materials for Viral Vaccines
- 02/25/2010 Tobacco-based Vaccine Initiative LaunchedFrom Texas A&M University
- 02/25/2010 Lilly Cited for Quality Issues in P.R. Humalog Facility
- All news »
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page